chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Surgeon MD, calls at 09:38AM (18AUG11), reporting that one of his SM's, received YF SC in LUE yesterday morning (17AUG11) around 08:30AM. SM's LUE began itching, swelling & tingling right above his left elbow yesterday evening, about 12 hours post receipt of immunization. SM did not have any difficulty breathing or swallowing or any swelling of face, lip, tongue or eyelids. SM applied ice pack to affected area x 2 hrs around 10PM last evening and fell asleep. When he woke up this AM, the upper and lower left arm was swollen, red and warm and felt tight & a little sore. Dr. states that the erythema and swelling extend from the SM's injection site, medially left upper arm, below his elbow to just above the SM's left wrist. The SM is able to move and bend his left arm, wrist, hand and fingers and has not lost any feeling in his left arm, hand, or fingers. Dr. states that SM has a (?) urticarial welt on the volar aspect of his left wrist. Surgeon gave SM 25 mg IM of BENADRYL and 10 mg po of ZYRTEC at 09:30AM (18AUG11). PLAN: SM will come to clinic for evaluation to R/O Type I Hypersensitivity Rxn vs. Arthous rxn-we recommended that SM be accompanied and NOT drive, but left clinical judgement to Surgeon. Reviewed SM's Imm record. SM received multiple live and inactivated vaccines a little over a week ago in preparation for deployment, possibly as early as next week or the beginning of SEP. SM received TYPHIM VI on 08AUG11. On 11AUG11, SM received Varicella (live virus) and inactivated AVA#3, MCG, Rabies#1 IM & Tdap. He was given YF yesterday (17AUG11) with less than 30 days between administration of live virus vaccines, as rec. SM says that he filled out a consent which asked if he had received others vaccines in the past 40 days, but he said no one looked at it before administering the YF vaccine. SM states that he has received some of his vaccines at Clinic and others at his station. He should be due a second dose of the Rabies pre-exposure series on day #7, which would be today, (not given). SM will be going to his sister's wedding this weekend. He will be leaving driving there tonight with his wife and states that his wife can drive. We cautioned SM against anti-histamine use (ZYRTEC or ATARAX for itching) if driving. Verbalizes understanding and compliance.
Nerve sensitivity, pain upon touching of entire left arm, neck, leg, chest/stomach x 5 days - extreme pain almost to the point of going to the emergency room; headache, chills, body aches, fever
I have an on going life long immune system problem. Allergies formed, I lost 25 pounds in one year without effort or even trying to lose the weight. I cannot remember a day when I didn't feel sick!
Got GBS, was on a vent for weeks, will always be a cripple & be disabled; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced guillain barre syndrome (serious criteria disability and GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was recovered/resolved.   It was unknown if the reporter considered the guillain barre syndrome to be related to Flu vaccine.     Additional Information: GSK Receipt Date: 25-Dec-2022. Reporter's Comment: This case was received from patient's friend via interactive digital media.  The reporter stated that got a friend (patient) that got it from Flu vaccine. Was on a vent for weeks.  The reporter stated this was years ago, the patient said she would always be a cripple and be disabled. The reporter also mentioned the Flu shot could also cause it and got a friend that would always be a cripple from the flu vaccine then got GBS (guillain barre syndrome). Additional Supportive Information: This case was one of 4 cases reported by same reporter. The follow up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR193091:Same reporter US-GSK-US2022AMR193110:Same reporter US-GSK-US2022AMR193112:Same reporter
This spontaneous report as received from a nurse via Poison and Drug Centre refers to an unknown number of patients of unknown age and gender. Patients' medical history, concurrent conditions and concomitant medication were not reported. On unknown dates in 2017, multiple unspecified patients were vaccinated with ROTATEQ for prophylaxis. Dosing details, route of administration, lot number and expiry date were unknown. On an unknown date, in the beginning of 2017, the vaccine was reported to have been out of range (incorrect product storage). It was reported that the other employees who record the temperature never reset the button. On 03-JAN-2017, for example, the "min/max" temperature was "33/47" (units unspecified) and she didn't reset the button. The temperature was observed to be 43 (units unspecified) when she arrived at the office and when she left, it was 47 (units unspecified). It was never observed to be out of that range. It was also reported that "on the 3rd, 4th, 5th, and 7th, everything was in the same range and was 43, 38, 35, 45, 43, or 45" (units unspecified). As of 06-MAY-2017, it was not known if the patients were still administered the ROTATEQ. This report is one of three reports that are linked via same reporter link. Additional information has been requested. Sender's Comments: US-009507513-1705USA007740: US-009507513-1705USA004287.
Dose was administered greater than 12 hours post first vial puncture.; dose was administered  greater than 24 hours at room temperature; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was administered greater than 12 hours post first vial puncture.) and PRODUCT STORAGE ERROR (dose was administered  greater than 24 hours at room temperature) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041J21A and 0331-12-1A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was administered greater than 12 hours post first vial puncture.). 24-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (dose was administered  greater than 24 hours at room temperature). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Dose was administered greater than 12 hours post first vial puncture.) and PRODUCT STORAGE ERROR (dose was administered  greater than 24 hours at room temperature) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.  Vial was first moved from freezer to refrigerator on 19-Jan-2022 and room temperature was 72F.Vial was first punctured on 23-Jan-2022 at 9:30am Date vial moved from freezer to refrigerator were 19-Jan-2022 to 25 -Jan-2022.
body ache and temperature started during Sunday evening  and lasted until Monday at 8:30 pm
pt recvd vax; rash 17mar, progressed to face,belly,arm,back; inc T 105; to MD; rash gone by 20MAR95, dec fever;
Patient received Monovalent Moderna 0.5ml blue cap purple label.  Patient was intended to receive Bivalant Moderna 0.5ml blue cap gray label.
Sever hot flash raising  heart rate  high blood pressure 192/112  the paramedics stay with me for an 1hr in a half I had high blood pressure it started 20min after the vaccine
2nd dose pfizer vaccine was given to patient on 07/06/2021. We found out on 07/09/2021 vaccine was stored outside the recommended 31 day expiration window.
Moderna vaccine mistakenly given for second dose; patient had previously received Pfizer.  Patient was planning for full Pfizer series. No symptoms at time of vaccine, no adverse reaction noted. Monitored for 15 minutes after vaccine per protocol. MD aware and discussed with family.
received expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 27th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 27th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 29-Aug-2022 Reporter's comment: The reporter consented to follow-up via email. Additional supportive information: The patient received an expired dose of Kinrix, which led to expired vaccine used.
After this patient received her first shingrix vaccine. She expressed that she had developed serveral lumps in her neck region. She said about 2-3 lumps. then more then the next day after. The lumps have not all disappeared now from date of her vacine in 9/21/21 till now 3/20/22. patient had went to serveral doctor visits because of this. she had a MMR and ultrasound done. Was told that they cysts. Its not difcult for her to swallow, but she said it is ugly to feel. She is concern that these lumps have not gone away, and concerned for the next dose of shingrix that she will not get again to complete the sequence
Migraine changed to headache for 24 hours.  Body aches and several body chills
Described in prior section  Redness, itching, warmth and raised red areas on left upper arm. Almost completely resolved (mild redness but fading) No treatment was required.
07/10/2015 radiologists MRI Cervical Spine [C-4 C-5 very mild bulging discs and osteophyte still does not correlate to arm severe arm weakness and growing paralysis. 07/10/2015 Dr Arm is growing more painful and increasing muscle atrophy and paralysis of motion. Reads shoulder MRI prescribes PERCOCET/orders MRI of neck. 07/08/2015 physical therapy PT. 07/06/2015 physical therapy PT. 07/02/2015 physical therapy PT. 07/01/2015 physical therapy PT. 06/27/2015 chiro adjustment no change. 06/26/2015 Physical therapy PT; 06/24/2015 physical therapy PT. 06/29/2015 Physical therapy PT. 06/17/2015 Physical therapy PT. 06/17/2015 radiologists MRI or right shoulder [mild tendonitis/insignificant cysts) Findings in report did not correlate to severity of symptoms. 06/16/2015 Chiro adjustment no change requested MRI right shoulder. 06/15/2015 Physical therapy PT. 06/13/2015 Dr 4 weeks physical therapy/continue ALEVE. 06/08/2015 Surgical specialty Xray again showed no significant injury. 06/08/2015 Dr ortho consult prescribed prednisone med pac and ALEVE. 06/07/2015 xray [did not show structural damage/prescribed naproxen 500 mg. 06/08/2015 chiro adjustment no relief. 06/04/2015 home Onset of severe arm pain beginning in elbow and working down to fingers and up to shoulder, scapula and neck. May/June '15 coach arm was progressively weakening and more painful with activity. Initially attributed to over use. March/April '15 coach arm was progressively weakening and more painful with activity. Initially attributed to over use. 1/9/2015 clinic Flu shot in right deltoid Sanofi FLUZONE Lot UI198AD Meningococcal in left deltoid Novartis MENVEO Lot M14082.
Shingles on back after second dose; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8732), dose 2 via an unspecified route of administration, administered in left arm on 01May2021 12:00 as 2nd dose, single dose (at the age of 62-years-old); and previously received BNT162B2(Lot Number: EW0150), dose 1 via an unspecified route of administration, administered in left arm on 10Apr2021 14:00 as 1st dose, single dose for COVID-19 immunization. No history of any previous vaccinations within 4 weeks. The patient's medical history and concomitant medications were not reported. Patient reported some people in her family had Chicken-pox. On 18May2021, after second dose, the patient experienced shingles on back which is ongoing at the time of report. Patient developed Shingles and did not think it was related to the vaccine. And patient does not think it is a coincidence that other people are developing Shingles, and maybe the vaccine is activating something inside of their body. No Investigation Assessment. Patient reports she was taking medication for shingles. Patient had a video doctor's visit. The outcome of event was unknown.  Follow up needed, further information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021576867 same reporter/drug/event, different patient;US-PFIZER INC-2021576866 same reporter/drug/event, different patient
Dtap vaccine administered instead of flu vaccine; Dtap vaccine to a 16 year old instead of the flu vaccine due to exactly the same box; This case was reported by a other health professional via other manufacturer and described the occurrence of wrong vaccine administered in a 16-year-old patient who received DTPa (Reduced antigen) (dTpa vaccine) for prophylaxis.   On an unknown date, the patient received dTpa vaccine. On an unknown date, unknown after receiving dTpa vaccine, the patient experienced wrong vaccine administered and product packaging confusion. On an unknown date, the outcome of the wrong vaccine administered and product packaging confusion were unknown.       Additional Information: GSK receipt date: 21-SEP-2022 Reporters comment:  The reporter reported that during a call a few years ago the GSK vaccines, Dtap and Fluarix had exactly the same box color and a nurse given the Dtap vaccine to a 16 year old instead of the flu vaccine. The reporter stated that this was reported and that the box colors are no longer the same and did not provide patient information or any additional information to further clarify these details.  The reporter consent to follow-up. Additional Supportive information: The nurse given the Dtap vaccine to a 16 year old instead of the flu vaccine due to exactly the same box color, which led to wrong vaccine administered and product packaging confusion.
OBSTRUCTIVE SLEEP APNEA 12/6/2022  -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Pt received vax and returned within 30 minutes with complaints of itchiness all over, hives and wheezing. Onset probably 10 minutes post vax.
patient received second dose a week after his first dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose a week after his first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose a week after his first dose). On 09-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose a week after his first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.
I began monitoring my blood pressure in early January 2023. I encountered some high systolic readings. The readings were in 140s and 150s. Previous systolic readings had been in the 120s. I was experiencing a high level of stress due to a family illness. My family member died at the end of January. I continued to monitor my blood pressure through February 2023. The high readings persisted. I sought medical attention on March 01, 2023. I was prescribed valsartan, 1 dose daily, to control high blood pressure. I've continued to monitor my blood pressure daily since the prescription was filled. I'm seeing moderate results in lowering blood pressure to date. I'm continuing to exercise most days when weather permits. I walk two miles daily.
She complained of sore neck under throat and swollen gland which started the day after Hep A vaccine.  She states she also had chills.
Vomiting, diarrhea, fussiness, pallor, intussusception like behaviors, about a week long from onset of symptoms.
Feeling shortness of breath since the day vaccine was received. Hard time catching my breath. Back pain started 4 days after vaccine and feeling fatigue since the day of the vaccine
This spontaneous report as received from a physician assistant refers to a female patient of unknown age. On an unknown date in June 2012 (reported as approximately one year ago) the patient was vaccinated with second dose of GARDASIL (dose, lot number and route of administration were not reported). On 18-JUN-2013 the patient was in the office to receive her 3rd dose of GARDASIL. Additional information has been requested.
Instant arm soreness and numbness. Arm muscle pain from about 2pm until about 9pm. Developing fatigue and headache by 2. At 9pm started to have sever rigors and had to move to a bed. Rigors for several hours with fever coming and going. Mild hallucinations while in bed and severe sweating. Woke up with left eye not responding but still had vision. Headache only on left side of head with severe pressure. Right sight felt normal. Right eye normal. Seemed like mix between edema and slight bell's pallsy. Could still move left side mouth and forehead. Eye was not responsive. Eye resolved after 2 days. Return to 100% about 96 hours after dose.
He was sleeping and had a nightmare and he woke up; Felt an immense cold; His body was shaking so strongly that he could not control it/his body was shaking so much; He was almost convulsing; Fever/mild fever/ body temperature of 40.1°C; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (He was sleeping and had a nightmare and he woke up), FEELING COLD (Felt an immense cold), TREMOR (His body was shaking so strongly that he could not control it/his body was shaking so much), FEELING ABNORMAL (He was almost convulsing) and PYREXIA (Fever/mild fever/ body temperature of 40.1°C) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035H21B) for COVID-19 vaccination.     The patient's past medical history included Bone operation (he does not have any underlying condition.).    On 23-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Dec-2021, the patient experienced SLEEP DISORDER (He was sleeping and had a nightmare and he woke up), FEELING COLD (Felt an immense cold), TREMOR (His body was shaking so strongly that he could not control it/his body was shaking so much), FEELING ABNORMAL (He was almost convulsing) and PYREXIA (Fever/mild fever/ body temperature of 40.1°C). The patient was treated with ACETAMINOPHEN on 24-Dec-2021 at a dose of two 350mg pills and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 24-Dec-2021 at a dose of 1 tablet. At the time of the report, SLEEP DISORDER (He was sleeping and had a nightmare and he woke up), FEELING COLD (Felt an immense cold), TREMOR (His body was shaking so strongly that he could not control it/his body was shaking so much) and FEELING ABNORMAL (He was almost convulsing) outcome was unknown and PYREXIA (Fever/mild fever/ body temperature of 40.1°C) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Dec-2021, Body temperature: 40.1°c (High) 40.1°C.         Concomitant product use was not provider by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2021: Follow up received include no new information.
Large (5x4cm ovoid) area of erythema and pruritus just below injection site on LUE. Lasted about one week and self resolved
Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided
Pt broke out with a rash of about 30 lesions and no fever. There was no known exposure to wild type virus. The pt was diagnosed with varicella.
Patient received Pfizer monovalent instead of Pfizer bivalent as a Covid-19 booster dose
positive COVID-19; This is a spontaneous report received from a contactable consumer reported for a male patient via a Pfizer-sponsored program. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 02Apr2021 at an unspecified dose as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 08Apr2021 finished quarantine on 18Apr2021. It was reported that she and her husband got their first dose last 02Apr2021 and scheduled to have their 2nd dose today 23Apr2021. Mentioned that both of them tested positive last 08Apr2021. Asked if they can still get the 2nd dose today or not. Also mentioned she finished quarantine last 18Apr2021 and her husband finished his quarantine yesterday. The patient experienced positive covid-19 on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient is mildly tachycardic, flushed, complaining of shortness of breath and sensation that her throat is closing.  Patient has some inspiratory stridor.  She was moved to a room and given intramuscular epinephrine, diphenhydramine, famotidine, and methylprednisolone.